A 58-year-old man with diabetes mellitus type 2 presents with nephrotic syndrome and declining renal function (eGFR 35 mL/min/1.73m²). Kidney biopsy shows nodular glomerulosclerosis (Kimmelstiel-Wilson nodules), hyaline arteriolosclerosis, and mesangial expansion. Which of the following is NOT consistent with diabetic nephropathy?

Explanation

## Diabetic Nephropathy: Pathological Features and Pathophysiology **Key Point:** Diabetic nephropathy is a **nodular glomerulosclerosis** with mesangial expansion and hyaline arteriolosclerosis. Crescents and fibrinoid necrosis are hallmarks of **rapidly progressive glomerulonephritis (RPGN)**, NOT diabetic nephropathy. ### Pathological Features of Diabetic Nephropathy 1. **Glomerular Changes** - **Kimmelstiel-Wilson nodules** (nodular glomerulosclerosis): pathognomonic, composed of PAS-positive hyaline material in the mesangium - Diffuse mesangial expansion and GBM thickening - NO crescents or fibrinoid necrosis (these indicate RPGN) 2. **Vascular Changes** - **Hyaline arteriolosclerosis**: homogeneous, eosinophilic material in arteriole walls (hallmark of diabetes) - Afferent arteriole dilation; efferent arteriole constriction (due to Ang II) - Intimal fibrosis and medial hypertrophy 3. **Tubular Changes** - Basement membrane thickening - Atrophy and dilation ### Proteinuria Pattern in Diabetic Nephropathy **High-Yield:** Diabetic nephropathy causes **selective proteinuria** (predominantly albumin, <3.5 g/day initially, progressing to nephrotic range). This is due to loss of negative charge on the GBM, not loss of size selectivity. ### Electron Microscopy Findings | Finding | Diabetic Nephropathy | RPGN | |---------|---------------------|------| | **GBM thickness** | Markedly thickened (>400 nm) | Normal or thin | | **Deposits** | No immune deposits | IgG, C3, fibrin | | **Mesangium** | Expanded with hyaline material | Normal or expanded | | **Crescents** | Absent | Present (defining feature) | | **Fibrinoid necrosis** | Absent | Present in capillary walls | ### Pathophysiology of Glomerular Hemodynamics ```mermaid flowchart TD A[Hyperglycemia]:::outcome --> B[Afferent arteriole dilation]:::action A --> C[Angiotensin II activation]:::action C --> D[Efferent arteriole constriction]:::action B --> E[Increased glomerular capillary pressure]:::outcome D --> E E --> F[Hyperfiltration]:::outcome F --> G[Proteinuria & GBM damage]:::outcome G --> H[Progressive glomerulosclerosis]:::outcome ``` **Clinical Pearl:** The initial phase of diabetic nephropathy is **hyperfiltration** (elevated GFR), which later progresses to declining GFR as glomerulosclerosis develops. Early intervention with ACE inhibitors or ARBs slows this progression by dilating the efferent arteriole and reducing intraglomerular pressure. ## Why Option 2 is Correct **Crescent formation with fibrinoid necrosis** is the defining pathological feature of **rapidly progressive glomerulonephritis (RPGN)**, which includes ANCA-associated vasculitis, anti-GBM disease, and immune complex RPGN. These findings are **NOT present in uncomplicated diabetic nephropathy**. Diabetic nephropathy shows nodular glomerulosclerosis without crescents or fibrinoid necrosis. **Warning:** A diabetic patient with crescents and fibrinoid necrosis likely has **superimposed RPGN** (e.g., ANCA-associated vasculitis) rather than pure diabetic nephropathy. This is a common clinical scenario requiring different treatment (immunosuppression vs. glycemic control alone). [cite:Robbins 10e Ch 20]